Literature DB >> 7783375

[Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study--a study of a efficient screening programme for stomach cancer].

Y Abe1, T Mitsushima, K Nagatani, H Ikuma, Y Minamihara.   

Abstract

An epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer was conducted with applying a method of case-control study. And also in order to carry out an efficient screening programme, the age groups who should be intensively recommended to receive screening and an optimal screening time interval since the last test were analyzed. 527 cases of men and 273 of women, dying of stomach cancer in the years 1981-1989 in the Awa region of Chiba prefecture, were identified from Chiba Cancer Registry. For each case, 3 controls were drawn at random from Awa living residents (about 162000 inhabitants at 1989 national census), with being matched strictly according to the district of residence, sex and born within 3 years of birth-year. For both cases and controls, the information about the screening history until the date of diagnosis of the case in each matched set was collected respectively from comparison with the screening certification. The results showed a relative risk of 0.417 (99% CI 0.284-0.612) in ever screened men compared with never screened and 0.480 (99% CI 0.280-0.823) in women. The significant reduction in risk was intensively observed on age groups 40-74 years among men and 50-69 years among women and the protective effect continued at most in the following three years since last screening. For an efficiency of screening programme, these age groups should be intensively recommended to receive screening and it is allowable that an optimal screening time interval since last negative test is at most 3 years for general attendance.

Entities:  

Mesh:

Year:  1995        PMID: 7783375

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  9 in total

1.  Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias.

Authors:  Hiroya Nakata; Shotaro Enomoto; Takao Maekita; Izumi Inoue; Kazuki Ueda; Hisanobu Deguchi; Naoki Shingaki; Kosaku Moribata; Yoshimasa Maeda; Yoshiyuki Mori; Mikitaka Iguchi; Hideyuki Tamai; Nobutake Yamamichi; Mitsuhiro Fujishiro; Jun Kato; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2011-08-16

2.  Confounding by dietary factors in case-control studies on the efficacy of cancer screening in Japan.

Authors:  Ko-Jun Suzuki; Shigeyuki Nakaji; Shoji Tokunaga; Tadashi Shimoyama; Takashi Umeda; Kazuo Sugawara
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Screening for and surveillance of gastric cancer.

Authors:  Debora Compare; Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital, Nagasaki Prefecture.

Authors:  Satohiro Matsumoto; Kazumi Yamasaki; Kenichiro Tsuji; Satoshi Shirahama
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

Review 5.  Screening for gastric cancer: the usefulness of endoscopy.

Authors:  Kui Son Choi; Mina Suh
Journal:  Clin Endosc       Date:  2014-11-30

Review 6.  Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?

Authors:  Gwang Ha Kim; Sung Jo Bang; Alexander R Ende; Joo Ha Hwang
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

7.  Personality and gastric cancer screening attendance: a cross-sectional analysis from the Miyagi Cohort Study.

Authors:  Shizuha Arai; Naoki Nakaya; Masako Kakizaki; Kaori Ohmori-Matsuda; Taichi Shimazu; Shinichi Kuriyama; Akira Fukao; Ichiro Tsuji
Journal:  J Epidemiol       Date:  2009-01-22       Impact factor: 3.211

8.  A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan.

Authors:  Chisato Hamashima; Kazuei Ogoshi; Mikizo Okamoto; Michiko Shabana; Takuji Kishimoto; Akira Fukao
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.

Authors:  Zhigang Huang; Xie Zhang; Hongna Lu; Lina Wu; Danping Wang; Qiubo Zhang; Huaxin Ding
Journal:  BMC Gastroenterol       Date:  2014-04-11       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.